Designing Paclitaxel Drug Delivery Systems Aimed at Improved Patient Outcomes: Current Status and Challenges

Figure 10

Survival rate of HeLa S-3 tumor cells exposing to emulsions and Diluent 12 with or without paclitaxel. ● represents the formulated emulsion with paclitaxel, ■ represents Diluent 12 containing 6 mg paclitaxel in 1 mL 50% ethanol and 50% Cremophor EL, respectively, ○ represents emulsion without paclitaxel, and □ represents Diluent 12 without paclitaxel (reproduced with permission from Kan et al., [61]).